EMA greenlights BioNtech’s COVID-19 vaccine
Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally approve BioNTechs mRNA vaccine BNT162b2 in the EU.
European Circular Bioeconomy Fund growing
Only two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.
Novo Holdings creates Hemab
Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.
Biotech companies launch Biotech Austria
Austria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.
How microplastic particles get into the body
Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.
Centogene and Anylam launch clinical programme
Diagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis.
Avantium NV bags money for demo plant
Green chemistry company Avantium NV has secured a 7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant.
How stress brings cancer to life again
Swiss Noema Pharma raises CHF54m in Series A financing
Noema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG.
Germany first EU country to launch COVID-19 therapy offensive?
After months of lobbying by the BIOM biotech cluster, Bavaria is launching a 50m initiative to push the best and fastest COVID-19 therapies.